{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:41:51Z","timestamp":1785156111901,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the capital health development fund","award":["201614035"],"award-info":[{"award-number":["201614035"]}]},{"name":"cams major collaborative innovation project","award":["2016-I2M-1-011"],"award-info":[{"award-number":["2016-I2M-1-011"]}]},{"DOI":"10.13039\/501100012226","name":"fundamental research funds for the central universities","doi-asserted-by":"publisher","award":["2019-XHQN09"],"award-info":[{"award-number":["2019-XHQN09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the youth research fund of peking union medical college","award":["2019-F11"],"award-info":[{"award-number":["2019-F11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12072-021-10252-0","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T16:15:06Z","timestamp":1633882506000},"page":"1337-1346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case\u2013control study"],"prefix":"10.1007","volume":"15","author":[{"given":"Hui-Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Xuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Gang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"issue":"1","key":"10252_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320 (Epub 2017\/09\/21)","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10252_CR2","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J |Hepatol. 2016;64(6):1388\u20131402","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"10252_CR3","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","volume":"115","author":"DQ Sun","year":"2021","unstructured":"Sun DQ, Jin Y, Wang TY, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433","journal-title":"Metabolism"},{"issue":"1","key":"10252_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"2","key":"10252_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/liv.14739","volume":"41","author":"Y Fouad","year":"2021","unstructured":"Fouad Y, Elwakil R, Elsahhar M, et al. The NAFLD-MAFLD debate: eminence vs evidence. Liver Int. 2021;41(2):255\u2013260","journal-title":"Liver Int"},{"issue":"7","key":"10252_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u20132014 (Epub 2020\/02\/12)","journal-title":"Gastroenterology"},{"issue":"11","key":"10252_CR7","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.3390\/ijms22115462","volume":"22","author":"S Fukunaga","year":"2021","unstructured":"Fukunaga S, Nakano D, Kawaguchi T, et al. Non-obese MAFLD is associated with colorectal adenoma in health check examinees: a multicenter retrospective study. Int J Mol Sci. 2021;22(11):5462","journal-title":"Int J Mol Sci"},{"key":"10252_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12754","author":"HS Chun","year":"2021","unstructured":"Chun HS, Kim MN, Lee JS, et al. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. J Cachexia Sarcopenia Muscle. 2021. https:\/\/doi.org\/10.1002\/jcsm.12754","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10252_CR9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10787-021-00842-7","volume":"29","author":"AL Han","year":"2021","unstructured":"Han AL. Association between metabolic associated fatty liver disease and osteoarthritis using data from the Korean national health and nutrition examination survey (KNHANES). Inflammopharmacology. 2021;29(4):1111\u20131118","journal-title":"Inflammopharmacology"},{"key":"10252_CR10","doi-asserted-by":"publisher","first-page":"693507","DOI":"10.3389\/fmed.2021.693507","volume":"8","author":"Q Huang","year":"2021","unstructured":"Huang Q, Zou X, Wen X, et al. NAFLD or MAFLD: which has closer association with all-cause and cause-specific mortality? Results from NHANES III. Front Med. 2021;8:693507","journal-title":"Front Med"},{"issue":"2","key":"10252_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12072-021-10157-y","volume":"15","author":"GTS Guerreiro","year":"2021","unstructured":"Guerreiro GTS, Longo L, Fonseca MA, et al. Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD? Hepatol Int. 2021;15(2):380\u2013391","journal-title":"Hepatol Int"},{"issue":"1 Suppl","key":"10252_CR12","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u2013S64","journal-title":"J Hepatol"},{"key":"10252_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.12.022","author":"H Lee","year":"2020","unstructured":"Lee H, Lee YH, Kim SU, et al. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.cgh.2020.12.022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10252_CR14","doi-asserted-by":"publisher","first-page":"e045762","DOI":"10.1371\/journal.pone.0245762","volume":"16","author":"MA Niriella","year":"2021","unstructured":"Niriella MA, Ediriweera DS, Kasturiratne A, et al. Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study. PLoS ONE. 2021;16(2):e045762","journal-title":"PLoS ONE"},{"issue":"3","key":"10252_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u2013477 (Epub 2019\/09\/11)","journal-title":"Eur Heart J"},{"issue":"12","key":"10252_CR16","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40(12):3018\u20133030","journal-title":"Liver Int"},{"issue":"7","key":"10252_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digest Liver Dis. 2010;42(7):503\u2013508","journal-title":"Digest Liver Dis"},{"key":"10252_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.02.027","author":"J George","year":"2021","unstructured":"George J, Gish RG, Geier A. MAFLD and cardiovascular events: what does the evidence show? Clin Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.027","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10252_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889\u2013919","journal-title":"Hepatol Int"},{"issue":"6","key":"10252_CR20","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/liv.14478","volume":"40","author":"Y Fouad","year":"2020","unstructured":"Fouad Y, Waked I, Bollipo S, et al. What\u2019s in a name? Renaming \u201cNAFLD\u201d to \u201cMAFLD.\u201d Liver Int. 2020;40(6):1254\u20131261","journal-title":"Liver Int"},{"issue":"5","key":"10252_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S2468-1253(20)30091-1","volume":"5","author":"The Lancet Gastroenterology H","year":"2020","unstructured":"The Lancet Gastroenterology H. Redefining non-alcoholic fatty liver disease: what\u2019s in a name? Lancet Gastroenterol Hepatol. 2020;5(5):419","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10252_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.31420","volume":"73","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Rinella ME, Sanyal AJ, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology. 2021;73(3):1194\u20131198","journal-title":"Hepatology"},{"issue":"9","key":"10252_CR23","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.14548","volume":"40","author":"S Lin","year":"2020","unstructured":"Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver int. 2020;40(9):2082\u20132089","journal-title":"Liver int"},{"issue":"1","key":"10252_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0038-1677517","volume":"39","author":"R Younes","year":"2019","unstructured":"Younes R, Bugianesi E. NASH in lean individuals. Semin Liver Dis. 2019;39(1):86\u201395","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10252_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384","journal-title":"Hepatology"},{"issue":"9","key":"10252_CR26","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/ajg.2014.155","volume":"109","author":"PJ Meffert","year":"2014","unstructured":"Meffert PJ, Baumeister SE, Lerch MM, et al. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis. Am J Gastroenterol. 2014;109(9):1404\u20131414","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10252_CR27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/ajg.2014.265","volume":"109","author":"J Cumberledge","year":"2014","unstructured":"Cumberledge J, Angulo P. Noninvasive prediction of hepatic steatosis. Am J Gastroenterol. 2014;109(9):1415\u20131416","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10252-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T02:05:30Z","timestamp":1638929130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10252-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10252"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10252-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Hui-Hui Liu, Ye-Xuan Cao, Jing-Lu Jin, Yuan-Lin Guo, Cheng-Gang Zhu, Na-Qiong Wu, Ying Gao, Rui-Xia Xu, Qian Dong, Ming-Hua Zheng and Jian-Jun Li declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were approved by the hospital\u2019s ethical review board (FuWai Hospital & National Center for Cardiovascular Diseases, Beijing, China) and complied with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors give final approval of the version to be published, and agree to be accountable for all aspects of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}